Complications néovasculaires d’un ostéome choroïdien : diagnostic et traitement
Journal Français d'Ophtalmologie · 2026
DOI: 10.1016/j.jfo.2026.104809 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal Français d'Ophtalmologie, 2026. Verfasst von E Scellier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre hospitalier de Simone-Veil, 40, avenue Léon-Blum, 60000 Beauvais, France. Electronic address: emma.scellier@gmail.com. Hauptthemen laut MEDLINE: Choroid Neoplasms, Choroidal Neovascularization, Osteoma. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Choroidal osteoma is a rare benign ocular tumor, with neovascular complications being even less common. The diagnosis is greatly facilitated by multimodal imaging techniques. However, treatment remains a challenge, as no standardized protocols exist, and current approaches rely primarily on intravitreal injections of anti-VEGF agents. CASE REPORT: We describe the case of a 45-year-old patient with no significant medical history who presented in 2020 with a progressive macular syndrome, characterized by decreased visual acuity and a central scotoma over several months. Ophthalmologic examination of the right eye was unremarkable, while the left eye showed reduced visual acuity of 3/10. The anterior segment was normal with a clear lens. Fundoscopy revealed a well-demarcated yellowish juxta-papillary subretinal lesion extending into the papillomacular area. Optical coherence tomography (OCT) demonstrated serous retinal detachment, intraretinal macular edema, and retinal pigment epithelial (RPE) detachments, along with a juxta-papillary eovascular membrane. A-scan ultrasonography confirmed the diagnosis of choroidal osteoma, showing a hyper-echogenic lesion with posterior shadowing. Retinal angiography and indocyanine green angiography (ICG) revealed occult neovascularization extending into the papillomacular area. The patient was treated with intravitreal anti-VEGF injections. Although the therapeutic response was gradual, injections every six weeks successfully maintained visual acuity at 7/10 and resolved the intra- and subretinal fluid. DISCUSSION AND CONCLUSION: The management of neovascular complications in choroidal osteoma remains complex due to the absence of standardized treatment protocols. Anti-VEGF therapy shows promise, albeit with a slow response, and requires sustained long-term administration to optimize visual outcomes and preserve visual function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre hospitalier de Simone-Veil, 40, avenue Léon-Blum, 60000 Beauvais, France. Electronic address: emma.scellier@gmail.com.
- Centre hospitalier de Simone-Veil, 40, avenue Léon-Blum, 60000 Beauvais, France.
Zitieren
APA
Scellier, E., Wathek, C., & Chaab, M. (2026). Complications néovasculaires d’un ostéome choroïdien : diagnostic et traitement. Journal Français d'Ophtalmologie. https://doi.org/10.1016/j.jfo.2026.104809
Vancouver
Scellier E, Wathek C, Chaab M. Complications néovasculaires d’un ostéome choroïdien : diagnostic et traitement. Journal Français d'Ophtalmologie. 2026. doi:10.1016/j.jfo.2026.104809
BibTeX
@article{Scellier2026,
author = {Scellier, E and Wathek, C and Chaab, M},
title = {Complications néovasculaires d’un ostéome choroïdien : diagnostic et traitement},
journal = {Journal Français d'Ophtalmologie},
year = {2026},
doi = {10.1016/j.jfo.2026.104809}
}
EUVIMED